Overview and SWOT analysis of nano-ferroptosis therapy for cancers

Abstract

Cancer remains one of the leading causes of death worldwide. In search for effective treatments, coventional therapies such as chemotherapy, radiotherapy, and immunotherapy have emerged as mainstream options. However, these therapies often come with significant side effects, resulting in unsatisfactory treatment outcomes. In contrast, the emerging field of nano-ferroptosis therapy holds considerable promise for cancer treatment, offering notable advantages in tumor targeting, mitigating drug resistance, and minimizing toxicity. Nano-ferroptosis therapy leverages nanocarriers with high loading capacities and structural tunability to deliver ferroptosis inducers, thereby inhibiting tumor growth through mechanisms such as the enhanced permeability and retention effect or active targeting for precise delivery to the tumor site. This review outlines the current status of research on nano-ferroptosis therapy for various cancer types, with a focus on four key aspects: strengths, weaknesses, opportunities, and threats (SWOT). Based on these insights, we propose recommendations and solutions for each aspect of the SWOT analysis. It is expected that this review will provide some insights for advancing nanomedicine design, deepening our understanding of ferroptosis mechanism, and guiding the development of more effective strategies for cancer treatment.

Supplementary files

Article information

Article type
Review Article
Submitted
21 Mar 2025
Accepted
29 May 2025
First published
31 May 2025

Nanoscale Horiz., 2025, Accepted Manuscript

Overview and SWOT analysis of nano-ferroptosis therapy for cancers

Q. Chen, J. Zhu, J. Jiang and Z. Huang, Nanoscale Horiz., 2025, Accepted Manuscript , DOI: 10.1039/D5NH00170F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements